Copertina

Dual KMT2A::USP2 and CBL::GRIK4 Fusions in Infant‐Type B‐ALL: A Case Report

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	ChengKan Du, Na Zhang, Min Xia, LinLin Jiang, WenHao Weng
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
di: Dong Peng, et al.
Pubblicazione: (2026)

Rare EWSR1::PBX1 Fusion‐Positive Infant B‐ALL With Coexisting KRAS Mutation: Sustained Molecular Remission Achieved With Standard Chemotherapy
di: Xiaoyong Chen, et al.
Pubblicazione: (2025)

Spontaneous remission in a case of neonatal leukemia with KMT2A gene rearrangement
di: Yuki Yasudome, et al.
Pubblicazione: (2024)

A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
di: Qiang Yao, et al.
Pubblicazione: (2025)

Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure
di: Luca Lo Nigro, et al.
Pubblicazione: (2025)

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐rearranged, therapy‐related acute lymphoblastic leukemia
di: Sanila Sarkar, et al.
Pubblicazione: (2024)

A Rare Case of Recurrent Infant Mediastinal Malignant Rhabdoid Tumor With MSH2 Germline Mutation
di: Qizi Wu, et al.
Pubblicazione: (2025)

Secondary T‐Lymphoblastic Lymphoma With KMT2A::MAML2 Rearrangement Following Myeloid Sarcoma and RUNX1::RUNX1T1‐Positive Acute Myeloid Leukemia
di: Ting Li, et al.
Pubblicazione: (2026)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
di: Qiang Yao, et al.
Pubblicazione: (2025)

A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML
di: Maya Ball‐Burack, et al.
Pubblicazione: (2025)

Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana‐Farber Cancer Institute ALL Consortium Study 16‐001
di: Alexandra Thrope, et al.
Pubblicazione: (2026)

Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16‐001
di: Sameera Ramjan, et al.
Pubblicazione: (2025)

A Rare Case of Concurrent Neuroblastoma and Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion: A Diagnostic and Therapeutic Dilemma
di: Laura M. Molina, et al.
Pubblicazione: (2025)

Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re‐Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B‐ALL
di: Paul S. Gaynon, et al.
Pubblicazione: (2024)

A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T‐Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications
di: Qiang Yao, et al.
Pubblicazione: (2025)

Overcoming Chemotherapy Resistance in EBF1–PDGFRB‐Positive B‐ALL: A Novel Therapeutic Approach Using Dasatinib and Blinatumomab
di: Jinyu Fu, et al.
Pubblicazione: (2025)

Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B‐ALL
di: Karen Lizeth Pachón‐Meza, et al.
Pubblicazione: (2025)

A Unique Case of Recurrence After Adjuvant Chemotherapy in Pleuropulmonary Blastoma (PPB) Type I With Transformation to PPB Type III
di: Mikhail A. Lemeshev, et al.
Pubblicazione: (2025)

Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation
di: Hilde Hylland Uhlving, et al.
Pubblicazione: (2024)

Evolving Pathological Stages of Severe Pulmonary Langerhans Cell Histiocytosis: Clinical Insights From a Case Involving an Infant
di: Ryunosuke Kudo, et al.
Pubblicazione: (2026)

Life‐Threatening Infantile Fibrosarcoma in an Infant
di: Katharina Daugs, et al.
Pubblicazione: (2025)

Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial
di: Maria C. Riccheri, et al.
Pubblicazione: (2025)

Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol
di: Merete Dam, et al.
Pubblicazione: (2024)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
di: Marko Kavcic, et al.
Pubblicazione: (2025)

Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
di: Mette Tiedemann Skipper, et al.
Pubblicazione: (2025)

Systemic Epstein–Barr Virus–Positive T‐Cell Lymphoma of Childhood: A Case Series
di: Maiah Zarrabi, et al.
Pubblicazione: (2026)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
di: Ashley C. Holland, et al.
Pubblicazione: (2025)

Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France
di: Dana Al Khalifa, et al.
Pubblicazione: (2025)

International Perspectives on Vitamin K Deficiency Bleeding in Infants: A Cross‐Sectional Questionnaire‐Based Survey
di: Nongnuch Sirachainan, et al.
Pubblicazione: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
di: Mikhail Lemeshev, et al.
Pubblicazione: (2026)

Primary Hepatic Choriocarcinoma With Pulmonary Metastasis in an Infant: Diagnosis and Treatment
di: Jie Zhao, et al.
Pubblicazione: (2025)

Comprehensive Genome Analysis Facilitates the Diagnosis of Ependymoma With ZFTA::NCOA2 Fusion
di: Riho Kikuchi, et al.
Pubblicazione: (2025)

A Rare Case of Pediatric Hepatocellular Carcinoma Secondary to Mitochondrial DNA Depletion Syndrome Type 3 ( DGUOK Mutation)
di: Tejasvi R, et al.
Pubblicazione: (2026)

Intestinal Spindle Cell Neoplasm With TPM4::NTRK1 Kinase Gene Fusion: A First Case Report in the Infantile Population
di: Anais Fohn, et al.
Pubblicazione: (2025)

Azacytidine Monotherapy in an Infant With Mosaic NRAS ‐Driven Juvenile Myelomonocytic Leukemia
di: Jeremy M. Grenier, et al.
Pubblicazione: (2025)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
di: Jessica A. O. Zimmerman, et al.
Pubblicazione: (2025)

Successful Management of Lineage Switch Infant Leukemia With Revumenib and Hematopoietic Cell Transplantation
di: Rachel E. Granberg, et al.
Pubblicazione: (2026)

Changes in Blood Test Indices of Infants With Down Syndrome‐Associated Transient Abnormal Myelopoiesis
di: Hideyuki Hawaka, et al.
Pubblicazione: (2025)

Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
di: Hetal Dholaria, et al.
Pubblicazione: (2025)

A Case of Pediatric Adrenocortical Carcinoma With McCune‐Albright Syndrome Masquerading as Spontaneously Regressing Neuroblastoma
di: Yu Lin, et al.
Pubblicazione: (2026)